© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software.

Slides:



Advertisements
Similar presentations
© 2011 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Advertisements

Joint TC Meeting: EHR – RCRIM RCRIM Overview HL7 Working Group Meeting January, 2007 Presented by: Ed Tripp Program Director, eSubmissions Abbott (RCRIM.
CDISC Content to Message HL7 Development Overview Jason Rock
Regulated Product Submissions R1 Overview January 12 th HL7 WGM Jason Rock
Infrastructures For Information Inc. The Collaborative XML Content Company Content Company.
Structured Product Labeling Overview
U.S. Food and Drug Administration
“Paperless Labeling Rule” Proposed Rule First Look January 2015.
©2014 Factorytalk Co., Ltd. Proprietary and Confidential eCTD Specification 17 July 2014.
CDRH Software Regulation
Requirements for Standardized Study Data: Update on Guidance Ron Fitzmartin, PhD, MBA Data Standards Program Office of Strategic Programs Center for Drug.
RPS WG Update March 2015 Open Stakeholder Session Nancy Shadeed Health Canada.
Overview of the New Content and Format Requirements for Prescription Drug Labeling.
DRAFT Guidance for Industry: Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing Denise Sánchez, J.D.,
EFPIA EFPIA IT Proposals ppt Slide 1 EFPIA Proposals for IT Support to the European Regulatory Procedures Mr S. Hasler EFPIA PAT Regulation 2000.
1 SPL Technology Presentation The Technology of Structured Product Labeling Presented by Robert H. Wallace 06 June 2004.
IMPLEMENTATION ISSUES
“So You Think You Know GCP …” Session S794 Jill Matzat, RN, BSN, CCRA, CCRT President, Medical Research Management & CRA Solutions, Inc. Paul Below, CCRA,
Regulatory Affairs Domain
Justina A. Molzon, MS Pharm, JD
HL7 Study Data Standards Project Crystal Allard CDER Office of Computational Science Food and Drug Administration February 13,
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
eCTD: Module 1 from submission to reviewer
Investigational New Drug Application (IND)
ICH V1 An FDA Update Min Chen, M.S., RPh Office of Drug Safety Center for Drug Evaluation and Research FDA January 21, 2003.
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
RCRIM Off-cycle Meeting Barbara Tardiff, Randy Levin and Ed Tripp, co-chairs.
Dave Iberson-Hurst CDISC VP Technical Strategy
DEPARTMENT OF HEALTH Medicines Regulatory Affairs
Kopenhagen, 22 April 2008 German CDISC User Group.
Regulated Product Submission HL7 Update Wednesday January 10 th, 2007 Jason Rock
Label Design Tool Management Council F2F Washington, D.C. November 29-30, 2006
MDIC 1 George Serafin Deloitte & Touche LLP MDIC Open Forum Quality System Maturity Model Update.
CTD Dossier Preparation K. Srikantha Reddy Sr
1 October, 2015 HL 7 Working Group Meeting. FDA UDI Rule – 9/24/2013 Unique device identifier (UDI) means an identifier that adequately identifies a device.
Labeling and Electronic Initiatives Rachel E. Behrman M.D., M.P.H. Deputy Director, Office of Medical Policy CDER FDA Science Board, April 15, 2005.
FDA ICH Public Meeting 5630 Fishers Lane, Rockville, MD May 8, :30 am -- 2:00 pm Implementation of the CTD Update-Issues-Next Steps Justina A. Molzon,
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
CDISC – 17/12/2012 Carine Javierre Nathalie SABIN.
1 CDISC HL7 Project FDA Perspective Armando Oliva, M.D. Office of Critical Path Programs FDA.
SAPRAA 5 Sept 2008 eCTD An overview of the full day presentation by Dr Olaf Schoepke at the SAAPI conference in July 2008.
Middle Fork Project Relicensing Process Plan April 25, 2006.
1 COMMON TECHNICAL DOCUMENT / ORIGIN OF CTD… ICH EWG CTD WAS OFFICIALLY SIGNED OFF IN NOVEMBER 2000, AT 5 TH ICH CONFERENCE; SAN DIEGO,CALIFORNIA.
DEPARTMENT OF HEALTH CENTER FOR BIOLOGICS AND HUMAN SERVICESEVALUATION and RESEARCH AND HUMAN SERVICES EVALUATION and RESEARCH Update on OCTGT Guidance.
Accurate  Consistent  Compliant Contact: i4i the structured content company the structured content company.
Fostering Antimicrobial Stewardship in Animals: Overview of FDA Activities William Flynn, DVM, MS Deputy Director for Science Policy Center for Veterinary.
IDMP Overview December 2015.
Regulated Product Submission Eileen M. Girten, MS i3 Statprobe 1DIA Education SIAC.
Validation Gary Gensinger Deputy Director Office of Business Process Support Center for Drug Evaluation and Research.
Regulated Product Submission Standard Overview Peggy Leizear FDA.
Regulated Product Submissions Goals and Scope Jason Rock x105.
ISO/HL Specification: Individual Case Safety Report (ICSR) Release 2 Lise Stevens Data Standards Project Manager FDA CBER/ADRM Bioinformatics Support.
Jim Bland Executive Director, CRIX International
Dave Iberson-Hurst CDISC VP Technical Strategy
eCTD: Module 1 from submission to reviewer
CTD Content Management
The Information Professional’s Role in Product Safety
Formal Meetings between FDA and Sponsors of PDUFA Products
eCTD Lifecycle Gary M Gensinger
Kimby N. Barton Interim Director Medical Devices Bureau
Combination products The paradigm shift
Gibraltar Financial Services Commission
Labeling and Electronic Initiatives
PhUSE Computational Science
Michael Gross, Ph.D., RAC Vice-President Worldwide Compliance
Business Cases and Advantages of eCTD v4.0
Fundamentals of Electronic Submissions and eCTD
Business View on eCTD v4.0 Advantages and challenges when considering implementation to overcome constrains of the current eCTD specification.
Optimzing the Use of Data Standards Calling for Volunteers
Presentation transcript:

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software Standards, IBM DIA ERS SIAC January 17, 2008

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 Topics What is RPS? RPS Timeline RPS Components What is SPL? SPL Timeline SPL Components Draft PDUFA IV Milestones and Strategy for RPS and SPL

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 RPS – Background, Focus & Components

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 What is RPS? RPS = Regulated Product Submission A Health Level 7 (HL7) standard intended to address multiple submission types - including those outside of human pharmaceuticals Initially targeted to address global health authority requirements Makes use of XML technology

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 What is RPS? Use XML to Describe: - dossiers overall - dossier sections - documents - relationships between documents or sections

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 Challenges Address submission types outside human pharmaceuticals – Vet, Food, Devices Have a “global” perspective Keep in mind current business process (eCTD) Keep in Mind Past Lessons Learned – for example from the eCTD and HL7 SPL

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 RPS Timeline Initiated 2005 –Wanted to leverage existing ICH eCTD work HL7 DSTU – Passed May 2006 –There were a set of 23 “storyboards” or requirements –Testing started based on requirements –First FDA test submission, Sept 2006 –Testing results were incomplete by Jan 2007 HL7 v1.0 Normative Standard, April 2007 –Passed ballot with a number of issues –Approved for FDA with regard to animal, foods and devices submissions

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 RPS Overview Reuse of Documents –By use of unique ID’s Product/Submission Management –Grouping based on message “units” –Application, Submission, Submission Units Categorization –Context of Use –Keywords

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 RPS Components Application –A group of submissions (“e.g. NDA, PMA”) Submission –A group of one or more submission units –In terms of an eCTD, a group of sequences –“e.g. original, supplement, variation” Reviewable Unit –Organizes a set of documents and data into discrete reviewable entities –“e.g. clinical”

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 RPS Components (2) Submission Units –A set of documents and data submitted to a regulatory agency at a specific time –In terms of the eCTD, one sequence Context of Use (“Table of Contents Heading”) –How documents/data are used in a specific submission unit –Protocol, Study Report, etc. Keyword –Further categorization of documents/data –Manufacturer #1, Animal Study, Food Color Study, Legacy Study Report

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 SPL – Background, Focus & Components

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 What is SPL? SPL = Structured Product Labeling A Health Level 7 (HL7) XML standard for the exchange of product information with the FDA Allows the XML to be submitted “stand alone” or as part of an eCTD submission Developed in an HL7 working group (RCRIM) – with FDA participation

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 SPL Timeline Adopted by CDER October 2005 Used to model existing labels Constraints defined by FDA implementation guide “Beginning June 30, 2006, content of labeling submitted to the Agency should be in the new format required in the Physician Labeling Final Rule (PLR) (21 CFR & 57)”

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 SPL Focus Content NOT format Allow updating of Product Information (PI) - to be used in place of the MS Word PI documents End user via daily med site eSubmission – either stand alone or as part of an eCTD

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 SPL Components HL7 Standard FDA Documentation: Implementation Guide, Stylesheets, etc. FDA SPL Review System (ELIPS) Associated business process changes SPL schema to define how a SPL submission should be formed to be valid

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 SPL Includes Content of labelling - narrative text of the labelling describing how and when to use medication Drug listing data elements or the structured format for describing the drug product including ingredients and packaging “Highlights” data elements - structured format for describing drug indications, drug class, drug interactions and adverse reactions

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 PDUFA IV Draft IT Plan – Milestones & Strategy: RPS & SPL

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 DRAFT PDUFA IV – Milestones RPS –Implement/Accept RPS Submissions in 1Q08 for: SPL Submissions to a Paper NDA/BLA Electronic datasets for paper IND/NDA/BLA Single investigator IND –RPS Release 1 HL7 Implementation Guide ready to be balloted 2Q08 –Target for addressing PDUFA requirements, RPS DSTU Release 2 – HL7 Ballot 3Q08 *NOTE: This information is from the Draft PDUFA IV IT plan, December 2007

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 DRAFT PDUFA IV – Milestones SPL –Electronic Listing to provide the ability to automate drug listing information and validation processes (SPL data elements to be extracted and reused). Prototype to be tested by FDA and Industry starting 1Q08. Release 1 targeted for 2Q08. –Collaboration Portal (CP) to provide a web based collaboration platform where applicants and the FDA can review and negotiate SPL labels. Prototype to be tested by FDA and Industry starting January –ELIPS Updates *NOTE: This information is from the Draft PDUFA IV IT plan, December 2007

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 DRAFT PDUFA IV Reference Link to FDA PDUFA IV Draft IT Plan

© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 Thank You! Terry Hardin IBM